Baseline and biennial DXA scans, adequate calcium/vitamin D, weight-bearing exercise, and early bisphosphonate initiation are recommended
New drug revolutionising the management of #obesity New kid on the block Check out the visual abstract of the #REMODEL trial #semaglutide @ISNkidneycare #ISNWCN @AnandhUrmila @drmanishasahay @myadla @arvindcanchi @isn_india Replying to @ISNWCN @SayaliBThakare and 33 others "Mechanistic effects of Semaglutide on kidney disease in type 2 diabetes: The REMODEL trial" by @KatherineTuttl8 et al, was awarded with the #ISNWCN Preserving Kidney Health: top scored abstract
Temperature-stable semaglutide maintains receptor activation potential, supporting consistent appetite suppression and metabolic benefits week to week
Patent Type Assay Compound : Active substance tested and measured in an assay to determine its activity or effect on a specific target
A study examining body composition changes 5-years post-semaglutide found those who gained weight displayed no significant changes in muscle area (188.9198.4 cm 2 ) at the lumbar spine (L3)-level, but gained visceral (313334 cm), subcutaneous (449486 cm), and intermuscular fat (37.648.4 cm), and experienced decreased muscle attenuation (13.15.9 HU), indicating higher muscle fat infiltration [16]